Stephen S. Yoder
2023
In 2023, Stephen S. Yoder earned a total compensation of $1.4M as Chief Executive Officer at Pieris Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $146,149 |
|---|---|
| Option Awards | $614,818 |
| Salary | $584,595 |
| Other | $13,390 |
| Total | $1,358,952 |
Yoder received $614.8K in option awards, accounting for 45% of the total pay in 2023.
Yoder also received $146.1K in bonus, $584.6K in salary and $13.4K in other compensation.
Rankings
In 2023, Stephen S. Yoder's compensation ranked 887th out of 3,006 executives tracked by ExecPay. In other words, Yoder earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 887 out of 3,006 | 71st |
Division Manufacturing | 519 out of 1,650 | 69th |
Major group Chemicals And Allied Products | 354 out of 918 | 61st |
Industry group Drugs | 344 out of 881 | 61st |
Industry Pharmaceutical Preparations | 234 out of 637 | 63rd |
Source: SEC filing on November 6, 2024.
Yoder's colleagues
We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2023.